CONFIDENTIAL CLIENT SEARCH
Interim Financial Evaluation & Modeling Consultant
Global veterinary pharmaceuticals organization
| Work Model |
Remote (United States) |
| Employment Type |
W2 contract; initial six-month engagement |
| Compensation |
Approximately $85/hour W2, with flexibility based on experience |
| Benefits |
Access to medical benefits, PTO, and 401(k) |
| Commitment |
40 hours per week |
| Schedule |
Monday-Friday, standard daytime business hours |
| Reports To |
VP, Global Business & Corporate Development |
The Opportunity
Korn Ferry is conducting a confidential search for an Interim Financial Evaluation & Modeling Consultant to support the Global Business & Corporate Development function of a growing, global veterinary pharmaceuticals organization. The organization is adding contract capacity while it evaluates the longer-term structure of this capability.
The consultant will develop robust financial models, evaluate investment opportunities, and support acquisitions, licensing arrangements, strategic partnerships, and internal product-development investments. This work requires the ability to convert complex scientific, clinical, regulatory, commercial, and market information into clear financial assumptions and recommendations.
Core mandate: determine what potential products, partnerships, licensing transactions, and acquisitions are worth-and provide the analysis needed to decide whether and how the organization should invest.
Key Responsibilities
Financial Modeling & Valuation
- Build and maintain complex financial models for acquisitions, licensing agreements, co-development partnerships, and product investments.
- Partner with Commercial and Market Intelligence teams to develop revenue forecasts for strategically aligned therapeutic areas.
- Lead valuation, scenario, and sensitivity analyses using DCF, risk-adjusted NPV (rNPV), IRR, EBITDA multiples, and other relevant methodologies.
Opportunity & Portfolio Evaluation
- Evaluate external business-development opportunities, including in-licensing, strategic collaborations, M&A, and external innovation projects.
- Translate scientific, clinical, regulatory, commercial, and market information into defensible financial assumptions.
- Prepare investment cases and business cases for senior leadership and investment committees.
- Provide financial input into portfolio prioritization, capital allocation, long-range planning, and pipeline valuation.
- Conduct market and competitive analyses to inform strategic and financial decisions.
Transaction Support
- Coordinate cross-functional due diligence with Regulatory, Commercial, HR, Legal, Manufacturing, Finance, and other project stakeholders.
- Lead financial due diligence, whether performed internally or with external advisors.
- Develop deal models and assess alternative structures involving upfront payments, milestones, royalties, and other economic terms.
- Support negotiation preparation by analyzing value drivers, risks, and structuring options.
Stakeholder Communication
- Prepare concise, decision-oriented materials for senior leadership and board-level discussions.
- Explain complex modeling outputs and valuation conclusions to non-financial stakeholders.
- Collaborate across Finance, R&D, Commercial, Regulatory, and other global teams to validate assumptions and align recommendations.
Required Qualifications
- Bachelor's or Master's degree in Finance, Economics, Accounting, or a closely related discipline.
- At least four years of relevant experience in corporate finance/M&A, transaction services, corporate development, investment banking, valuation, or strategic finance.
- Demonstrated hands-on ownership of complex financial models and transaction or investment evaluations.
Technical & Collaboration Capabilities
- Strong working knowledge of DCF, rNPV, IRR, EBITDA multiples, sensitivity analysis, revenue forecasting, and business-case development.
- Track record of identifying, evaluating, or supporting transactions and strategic investment opportunities.
- Excellent written and verbal communication skills, including the ability to present financial conclusions to senior and non-financial stakeholders.
- Experience working across functions and geographies in a global or matrixed environment.
- Advanced Microsoft Excel skills.
Preferred Qualifications
- Corporate development, transaction, commercial-strategy, or financial-evaluation experience within animal health, pharmaceuticals, biotechnology, or life sciences.
- Understanding of pharmaceutical or animal-health product development, therapeutic areas, regulatory pathways, and global commercial dynamics.
- ACA, CFA, or an equivalent professional qualification.
- Experience with licensing economics, including upfront payments, development and commercial milestones, and royalty structures.
- Power BI experience.
- Experience working across North America, Europe, LATAM, and Asia-Pacific markets.
- Exposure to digital health, AI-enabled business development, or innovative go-to-market models.
Measures of Success
- Quality, accuracy, and robustness of financial models and valuation analyses.
- Meaningful contribution to successful licensing, partnership, product-investment, and acquisition decisions.
- Timely delivery of clear, decision-ready strategic and financial insights.
- Effective collaboration across financial, scientific, regulatory, commercial, and operational stakeholders.
About Korn Ferry
Korn Ferry unleashes potential in people, teams, and organizations. We work with our clients to design optimal organization structures, roles, and responsibilities. We help them hire the right people and advise them on how to reward and motivate their workforce while developing professionals as they navigate and advance their careers. To learn more, please visit Korn Ferry at www.Kornferry.com
